TRPM2 and prostate carcinoma: Moreover, expression of TRPM2 has been demonstrated in several tumor entities such as insulinoma [6], hepatocellular carcinoma [6], prostate cancer [11], lymphoma [12], leukemia [13], and lung cancer cell lines [14] in which TRPM2 reportedly may foster cell death [15].